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Predictors of Clostridium Difficile Colitis Infections in Hospitals.
Abstract
Hospital-level predictors of high rates of 'Clostridium difficile-associated disease' (CDAD) were evaluated
in over 2300 hospitals across California, Arizona, and Minnesota. American Hospital Association data
were used to determine hospital characteristics associated with high rates of CDAD. Significant
correlations were found between hospital rates of CDAD, common infections and other identified
pathogens. Hospitals in urban areas had higher average rates of CDAD; yet, irrespective of geographic
location, hospital rates of CDAD were associated with other infections. In addition, hospitals with 'high
CDAD' rates had slower turnover of beds and were more likely to offer transplant services. These results
reveal large differences in rates of CDAD across regions. Hospitals with high rates of CDAD have high
rates of other common infections, suggesting a need for broad infection control policies.
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SUMMARY
Hospital-level predictors of high rates of ‘ Clostridium diﬃcile-associated disease ’ (CDAD) were
evaluated in over 2300 hospitals across California, Arizona, and Minnesota. American Hospital
Association data were used to determine hospital characteristics associated with high rates of
CDAD. Signiﬁcant correlations were found between hospital rates of CDAD, common infections
and other identiﬁed pathogens. Hospitals in urban areas had higher average rates of CDAD ; yet,
irrespective of geographic location, hospital rates of CDAD were associated with other infections.
In addition, hospitals with ‘high CDAD ’ rates had slower turnover of beds and were more likely
to oﬀer transplant services. These results reveal large diﬀerences in rates of CDAD across regions.
Hospitals with high rates of CDAD have high rates of other common infections, suggesting a
need for broad infection control policies.

INTRODUCTION
Clostridium diﬃcile-associated disease (CDAD) is
a common cause of nosocomial diarrhoea and is associated with substantial morbidity and mortality [1].
Recent population-based data reveal an increase in
the prevalence and severity of CDAD in the United
States [1, 2]. Changes in the epidemiology of C. diﬃcile may be secondary to the emergence of epidemic
strains in many areas of the United States and
Canada [3, 4]. In addition, others have demonstrated
* Author for correspondence : R. Ricciardi, M.D., M.P.H.,
Department of Colon and Rectal Surgery, Lahey Clinic, 41 Mall
Road, Burlington, MA 01805, USA.
(Email : rocco.ricciardi@lahey.org)

reduced eﬃcacy of usual medical therapies, such as
metronidazole and vancomycin, although resistance
to these agents has not been demonstrated [5, 6].
A number of authors have sought to deﬁne patientlevel risk factors that predispose patients to CDAD.
Most such analyses have examined patient demographics [7–9], comorbid conditions [10–12], clinical
variables [7, 8], and antibiotic treatment characteristics [7, 8, 13]. Patient-level risk factors have been
used to help develop treatment algorithms [14], and
may also be useful in developing prevention and
control measures.
Most cases of CDAD are transmitted while patients
are in the hospital, often through contamination of
the hands of hospital personnel caring for them [9].
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A recent county-level evaluation in Sweden revealed
that hospital-acquired CDAD is 1300 times more
common than community-acquired infections [15].
Thus, eﬀective prevention and control measures are
needed to reduce acquisition of CDAD. An evaluation of hospital-level characteristics may be more
useful than a focus solely on patient-level factors.
For this reason, an analysis of hospitals with the
highest proportion of CDAD and their risk factors is
needed. In this study, high rates of CDAD were
compared to hospital admission, personnel, and service characteristics for hospitals with high rates of
CDAD and compared to those with fewer CDAD
cases.

METHODS
Data sources
Hospital in-patient discharge data, which contain
greater than 95% of all discharge abstracts of nongovernment in-patient facilities, were obtained for
California, Arizona, and Minnesota. These data provided information on patient demographics, socioeconomic factors, admission proﬁles, hospital
proﬁles, state codes, discharge diagnoses, procedure
codes, total charges, and vital status at hospital discharge. Data use agreements are held by the respective state data collectors, so all study protocols were
considered exempt by the University of Minnesota
institutional review board.
The American Hospital Association (AHA)
Annual Survey of Hospitals database for the time
period January 2000–December 2003 was obtained in
order to determine hospital structural and service
lines associated with high rates of CDAD. The AHA
database contains hospital-speciﬁc information on
over 6000 hospitals and over 450 health-care systems,
including 700 data elements [16]. The purpose of the
AHA database is to generate a comprehensive and
inclusive overview of hospitals while permitting the
tracking of hospital performance over time. AHA
data have been extensively used to study hospitalbased outcomes [17], hospital policies [18], and reimbursement [19].
Hospital infection rates
Diagnostic codes from the International Classiﬁcation of Diseases (ICD-9) were used to identify
all patients who were discharged with a diagnosis of

C. diﬃcile-pseudomembranous colitis (ICD-9 code
8.45) [1, 2] from January 2000 to December 2003.
Patients with either a primary or secondary diagnosis
of CDAD were summed to calculate yearly hospital
rates/1000 discharges. Hospitals were divided into
two groups: Those whose CDAD rates were in
the 90th percentile of all hospitals studied (‘ high
CDAD ’ hospitals) and the remaining hospitals.
Psychiatric facilities, chemical dependency facilities,
and hospitals with incomplete information were excluded.
To test the association between CDAD and other
infections, previously published methods of identifying common infections as well as an estimate of other
bacterial infections were used. First, the proportion of
patients with discharge diagnoses of other commonly
treated infections, i.e. pneumonia [20], urinary tract
infections [21], endocarditis [22], cellulitis [23],
bloodstream infections [24], and osteomyelitis [25]
for the entire cohort, for each state, and for each
hospital was determined. Next, the proportion of
admissions for each of these infections to the total
of individual hospital discharges was calculated.
In addition, the rate of discharges for other common
bacterial infections (Escherichia coli, Pseudomonas,
Streptococcus, and Staphylococcus) was calculated
for the entire cohort, for each state, and for each
hospital.
AHA variables
Survey results from the AHA ﬁles were used to include the time period from January 2000 to December
2003. The hypothesis tested was that hospitals with
high rates of CDAD can be characterized by particular hospital characteristics, speciﬁcally hospital structural, personnel, and service-line data. These
characteristics were chosen because of the ease of
obtaining these variables and because high institutional rates of CDAD have been described in particular types of facilities [26, 27] and these ﬁles were
merged with the administrative hospital data described previously. First, hospital structural characteristics and service lines were evaluated. Staﬃng
characteristics were determined in terms of the number of full-time-equivalent medical doctors, registered
nurses, and medical residents as well as other hospital
factors such as distinction as a critical access hospital
for hospitals with <25 beds, presence of an emergency department, and total number of annual surgical
procedures.

Hospital risk factors for C. diﬃcile
Statistical analysis
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A correlation analysis was used to assess associations
between the rates of CDAD and the rates of other
bacterial infections. Similarly, the rates of CDAD
were compared with rates of six common infections
(pneumonia, urinary tract infections, endocarditis,
cellulitis, bloodstream infections, and osteomyelitis).
The mean rate of these infections and of four other
bacterial species (E. coli, Pseudomonas, Streptococcus,
and Staphylococcus) was determined for ‘high
CDAD ’ hospitals and all other hospitals. x2 tests were
used to compare categorical variables (AHA data)
and analysis of variance for continuous variables
(mean rates of infection).
A logistic regression model was constructed to
evaluate the relationship between ‘high CDAD ’ hospitals in the 90th percentile of CDAD infections
(categorical variable) and AHA characteristics. For
this analysis, variables from the AHA ﬁles and the
hospital location were included, while excluding infection variables because of the strong correlations
between CDAD, other bacterial pathogens, and other
common infections. The AHA categorical variables
included were : characterization as a trauma facility,
critical access hospital, patient burn beds, residents
in training, haemodialysis, neurology, orthopaedic,
palliative care, transplant, emergency department,
cardiac intensive care, and rehabilitation services.
AHA continuous variables were number of full-time
medical doctors, registered nurses, hospital beds and
surgical procedures in tertiles. The total annual hospital discharge ﬁgure was divided by total hospital
beds in order to estimate patient bed turnover by
facility. A comparatively high bed turnover ratio
indicates a shorter length of stay (variable entered
into model as a continuous variable). A similar
analysis was performed for ‘high CDAD ’ hospitals
for each state.

12·0

RESULTS
Cohort characteristics
This analysis reﬂects the characterization of 20292499
discharges over the 4-year study period. Of these
discharges, 80 619 patients had CDAD codes giving
a rate of 3.97 CDAD infections/1000 discharges.
The rate of CDAD for each metropolitan statistical
area is presented in the Figure. Hospitals in the
most populous localities had the highest rates of
CDAD.

CDAD/1000 discharges

Non-metropolitan
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Metropolitan

10·0
8·0
6·0
4·0
2·0
0·0
MSA (0)

MSA (2) MSA (3) MSA (4) MSA (5) MSA (6)

Very rural

Very urban

Fig. Mean number (with S.E.M.) of C. diﬃcile colitis
cases (number of cases/1000 hospitalized patients) by
metropolitan statistical area (MSA). Code : MSA 0, nonmetropolitan area ; MSA 1, <100 000 population ; MSA 2,
100 000–250 000 population ; MSA 3, 250 000–500 000
population ; MSA 4, 500 000–1 000 000 population ; MSA 5,
1 000 000–2 500 000 population ; MSA 6, >2 500 000 population.

Hospital-level analysis
Hospital characteristics
Data were available for 2363 acute care hospitals in
the three states. CDAD was noted in 2075 hospitals
(87.8 % of the total). The mean hospital rate (¡S.D.)
for CDAD was 6.3¡18.5 infections/1000 discharges.
The mean hospital rate for the other bacterial infections was greatest for E. coli (13.5¡9.4 infections/
1000 discharges), followed by Staphylococcus,
Streptococcus, and Pseudomonas (Table 1). Other
infections were noted in the majority of hospitals.
Almost all hospitals treated at least one patient with a
urinary tract infection (98.9%), pneumonia (98.7%),
cellulitis (98.5 %), bloodstream infection (97.0%),
and osteomyelitis (90.3 %) ; only 71.4 % of hospitals
treated at least one patient with endocarditis. The
mean hospital rate for the other infections was highest
for pneumonia (93.0¡72.3 cases/1000 discharges),
followed by urinary tract infections, cellulitis, bloodstream infections, osteomyelitis, and endocarditis
(Table 1).
Hospital characteristics were obtained from the
AHA data for the majority of hospitals. The data revealed that the hospitals averaged 176.6¡155.2 beds,
5248¡5208 annual surgical procedures, and
8270¡8533 discharges. A minority of hospitals admitted trauma patients (20.6%), provided transplant
services (7.4%), or had beds assigned for burn
patients (3.3 %). Only 35.7% provided cardiac intensive care services (Tables 2 and 3).

916

R. Ricciardi and others

Table 1. Hospital characteristics (for bacterial
isolates and commonly treated infections)
Hospital infection rate
(per 1000 discharges)
C. diﬃcile
E. coli
Pseudomonas
Staphylococcus
Streptococcus
Bloodstream
Cellulitis
Endocarditis
Osteomyelitis
Pneumonia
Urinary tract

6.3¡18.5
13.5¡9.4
4.6¡9.0
11.5¡15.3
6.5¡6.6
24.9¡35.5
27.5¡17.8
1.0¡2.0
5.3¡10.4
93.0¡72.3
72.0¡49.4

‘ High CDAD ’ hospitals and infections

Values are mean¡S.D.

Table 2. Hospital characteristics (proportion of
hospitals with identiﬁed service oﬀering)
Proportion of
hospitals with
service (%)
Emergency department services
Orthopaedic services
Cardiac intensive care services
Neurology services
Haemodialysis services
Rehabilitation services
Trauma hospital
Palliative care services
Critical access hospital
Transplant hospital
Patient burn beds

71.4
50.0
35.7
32.0
27.7
23.6
20.6
19.5
10.4
7.3
3.3

Table 3. Hospital characteristics (hospital beds,
staﬃng levels, and bed turnover)
Mean per hospital
Hospital beds
Total surgical procedures
Full-time medical doctors
Full-time registered nurses
Full-time residents
Bed turnover (discharges/bed)

Pseudomonas was highest, followed by Staphylococcus, Streptococcus, and E. coli (Table 4). Statistically signiﬁcant correlations were also found between
CDAD and bloodstream infections, followed by endocarditis, osteomyelitis, pneumonia, urinary tract
infections, and cellulitis (Table 5).

176.6¡155.2
5248¡5208
17.1¡71.4
154.9¡197.9
15.8¡67.2
44.2¡27.1

Values are mean¡S.D.

Infection correlations
Statistically signiﬁcant correlations for hospital
rates of CDAD and the other bacterial pathogens
were noted. The correlation between CDAD and

A group of hospitals was identiﬁed as having a disproportionately higher rate of CDAD, a plot of
CDAD for each facility revealed an inﬂection point
at which the rate of cases increased disproportionately. This inﬂection point of CDAD was
identiﬁed at the 90th percentile of all infections. ‘High
CDAD ’ hospitals had on average ten times more
CDAD cases than all other hospitals (Table 6).
A comparison of the rates of bacterial pathogens and
other common infections between ‘high CDAD ’
hospitals and all other facilities (Table 6) revealed
that the former were more likely to have E. coli,
Staphylococcus, Streptococcus, and Pseudomonas
infections (Table 6) and were also more likely to discharge patients with bloodstream infections, endocarditis, osteomyelitis, pneumonia, urinary tract
infections, and cellulitis (Table 6). Hospitals in the
95th or 80th percentile of CDAD also showed similar
associations.
‘ High CDAD ’ hospitals and hospital variables
A univariate analysis of hospital variables for ‘high
CDAD ’ hospitals (90th percentile of C. diﬃcile infections) compared to others revealed that the former
were less likely to provide neurology, orthopaedic,
and palliative care services ; in addition, they had
fewer nurses and residents, performed fewer operations, discharged fewer patients and were characterized by slower bed turnover. Lastly, ‘high CDAD ’
hospitals were not more likely to be classiﬁed as
critical access facilities (Table 7).

State analysis
The median number of cases of CDAD cases was
similar for California and Arizona and lowest for
Minnesota. Despite the small diﬀerence in the median
number of cases across the three states, the mean
case rate (¡S.D.) across states/1000 discharges were
Arizona 11.1¡30.1 cases ; California 6.5¡18.4 cases ;
Minnesota 2.9¡3.2 cases. In addition, the rate of
CDAD among the hospitals in the 90th percentile of

Hospital risk factors for C. diﬃcile
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Table 4. Bacterial correlations [correlation values (r) for individual pathogens in identiﬁed infections]

C. diﬃcile
E. coli
Pseudomonas
Staphylococcus
Streptococcus

C. diﬃcile

E. coli

Pseudomonas

Staphylococcus

Streptococcus

1

0.188
1

0.762
0.360

0.692
0.343
0.789

0.575
0.478
0.664
0.630
1

1

1

Table 5. Infection correlations [correlation values (r) for common infections]

C. diﬃcile
Bloodstream
Cellulitis
Endocarditis
Osteomyelitis
Pneumonia
Urinary tract

C. diﬃcile

Bloodstream

Cellulitis

Endocarditis

Osteomyelitis

Pneumonia

Urinary tract

1

0.683
1

0.452
0.513
1

0.626
0.461
0.400

0.610
0.514
0.560
0.533

0.584
0.718
0.587
0.333
0.405

0.570
0.623
0.652
0.347
0.432
0.737
1

1

1

1

Table 6. Hospital characteristics by CD colitis rate [diﬀerences in mean
rates (¡S.D.) of bacterial and infection characteristics between ‘high
CDAD ’ hospitals and all other facilities]
‘ High CDAD ’
hospitals

All other
hospitals

P value

Bacterial characteristics
C. diﬃcile
E. coli
Pseudomonas
Staphylococcus
Streptococcus

36.9¡48.5
19.8¡12.7
16.2¡23.5
33.1¡38.5
14.2¡13.9

2.9¡2.9
12.3¡8.7
3.3¡3.5
9.1¡6.1
5.6¡4.4

0.0001
0.0001
0.0001
0.0001
0.0001

Infection characteristics
Bloodstream
Cellulitis
Endocarditis
Osteomyelitis
Pneumonia
Urinary tract

70.6¡93.3
46.1¡31.1
3.0¡5.2
16.5¡2.7
184.1¡146.0
142.7¡94.7

19.8¡13.1
25.4¡14.3
0.8¡0.9
4.1¡4.8
82.8¡49.2
64.0¡33.0

0.0001
0.0001
0.0001
0.0001
0.0001
0.0001

Values are mean rate/1000 discharges¡S.D.

C. diﬃcile cases was highest for Arizona (83.7 cases/
1000 discharges), followed by California (36.5 cases),
and lowest for Minnesota (10.3 cases).
Comparison of ‘high CDAD ’ hospitals (in the 90th
percentile) for each state revealed patterns similar
to those in the complete cohort analysis described
above. With few exceptions, there were signiﬁcant
correlations between CDAD rates and isolates of
other pathogens as well as other common infections
for hospitals in the state of California, Arizona, or
Minnesota and results for individual hospital

reproduced those for the larger cohort. ‘High CDAD ’
hospitals had fewer full-time registered nurses, fewer
medical residents, fewer hospital beds, and performed
fewer surgical procedures. There was also a signiﬁcantly slower bed turnover (total discharges per bed)
as found in the wider cohort analysis.
Multivariate analysis
Logistic regression analysis revealed that hospitals
with transplant services [odds ratio (OR) 2.36, 95 %
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Table 7. Hospital characteristics by CD colitis rate (diﬀerences in hospital characteristics between ‘high CDAD ’
hospitals and all other facilities)
‘High CDAD’
hospitals
Hospital characteristic
(proportion of hospitals with service line)
Trauma hospital (%)
Critical access hospital (%)
With patient burn beds (%)
Haemodialysis services (%)
Neurology services (%)
Orthopaedic services (%)
Palliative care services (%)
Transplant hospital (%)
Emergency department services (%)
Cardiac intensive care services (%)
Rehabilitation services (%)
Hospital characteristic
[number of staﬀ, beds, discharges (mean¡S.D.)]
Full-time medical doctors
Full-time registered nurses
Full-time residents
Hospital beds
Total surgical procedures
Total yearly discharges
Bed turnover (discharges/bed)

conﬁdence interval (CI) 1.15–4.93] were more likely to
be in the 90th percentile of CDAD cases. Hospitals
with emergency department services (OR 0.52, 95 %
CI 0.32–0.84) or trauma services (OR 0.29, 95 % CI
0.13–0.62) were less likely to be in the 90th percentile
and so were hospitals with faster bed turnover (OR
0.96, 95 % CI 0.95–0.97). After adjusting for the
above factors, the state in which the hospital was located and other AHA data variables were also not
associated with high CDAD rates. Given that the
majority of the latter hospitals were located in
California and Arizona, a cohort of such hospitals
was constructed for each state. A new cohort of hospitals that represented the 90th percentile of CDAD
cases for each state was abstracted and the same
multivariate analysis was conducted. This analysis
revealed similar ﬁndings of increased risk of CDAD in
hospitals with transplant services but decreased risk
of CDAD in hospitals with emergency department
services, trauma services, and faster bed turnover as
well as an additional increased risk in hospitals providing haemodialysis services (OR 1.87, 95 % CI
1.09–3.21).

6.7
15
2.1
23.7
23.7
33.7
12.4
8. 5
42.4
26.1
18.0

14.0¡86.9
112.4¡170.5
4.7¡43.4
131.4¡112.8
3396¡4227.1
4298¡5828.8
25.8¡21.5

All other
hospitals

21.9
11.2
3.4
28.1
32.8
51.6
20.2
7.2
73.3
36.6
24.1

17.4¡69.0
159.3¡199.2
17.0¡68.8
181.4¡158.2
5441¡5257.1
8713¡8672.8
46.1¡26.9

P value

0.001
n.s.
n.s.
n.s.
0.03
0.001
0.01
n.s.
0.0001
0.01
n.s.

n.s.
0.0008
0.01
0.0001
0.0001
0.0001
0.0001

DISCUSSION
This study examined hospital-level predictors of high
rates of CDAD in over 2300 hospitals across
California, Arizona, and Minnesota. The analysis of
hospital characteristics is particularly useful, since
most CDAD cases are acquired while patients are
hospitalized [15]. Signiﬁcant correlations between
‘ high CDAD ’ hospitals and facilities that admit large
numbers of patients with other bacterial pathogens
and other common infections was noted. In addition,
although ‘high CDAD ’ hospitals were more likely to
provide transplant services, they were less likely to
provide emergency department services or trauma
services. The analysis by state revealed that the highest rates of CDAD occurred in Arizona; the lowest
rates, in Minnesota. Thus, the present study revealed
large variations in CDAD cases, with a clustering of
common infections at ‘ high CDAD ’ hospitals.
Prior to this study, attempts to identify risk factors
for CDAD have been conducted at the patient level.
Pepin and colleagues found that older patients with
multiple comorbidities were more likely to develop

Hospital risk factors for C. diﬃcile
CDAD [7] as were patients treated with proton pump
inhibitors [28] or tube feedings [29]. Most have described an association between antibiotics, particularly the use of cephalosporins, clindamycin, or
ﬂuoroquinolones and CDAD [7, 30–34]. There were
large diﬀerences in CDAD cases across hospitals,
metropolitan statistical areas, and states. These differences are probably due to clustering of infections
at particular facilities as was evident in the state
analyses. State rates of CDAD demonstrated considerable diﬀerence between median and mean case
rates and these were probably due to signiﬁcant outbreaks of infection at particular types of facilities.
This is further reinforced by the fact that ‘ high
CDAD ’ hospitals had more than 10 times the number
of CDAD cases than other hospitals while treating a
signiﬁcantly larger proportion of other common infections. Given this clustering of CDAD, it seems
particularly important that prevention and control
measures be applied in such high-risk hospitals. At
this time a number of methods have been developed
to reduce CDAD cases, including education, infection
control measures (e.g. contact precautions or patient
isolation), rigorous cleaning and disinfection protocols, and antibiotic restrictions [35, 36]. Although all
hospitals should attempt to reduce outbreaks of
CDAD, those with high numbers of other common
infections are most in need of prevention and control
measures.
In addition to hospital structural and personnel
characteristics, the present study revealed that hospitals with high numbers of Pseudomonas and
Staphylococcus infections were much more likely to
diagnose and treat CDAD. ‘High CDAD ’ hospitals
also had high numbers of endocarditis and bloodstream infections which generally require prolonged
hospital stay and antibiotic use, leading to a potentially higher CDAD risk. These ﬁndings are in agreement with the bed turnover ratio results, indicating
that those facilities with a slower turnover of patients
are at higher risk of CDAD. Hospitals with slower
bed turnover rates and therefore increased CDAD
rates may potentially have increased comorbidity or
patient severity of illness. Others have described
similar associations when comparing patient-level risk
factors for CDAD [11–13].
The association between CDAD and other infections is probably due to the mechanism by which
C. diﬃcile causes disease, i.e. by reducing normal colonic ﬂora with antibiotics used to treat another
infection, followed by patients’ inoculation with
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C. diﬃcile spores [33, 34]. Despite the long-held view
of CDAD pathophysiology, a recent systematic review investigated the association of antibiotics with
CDAD in order to summarize the strength of the
evidence for this relationship [37]. These researchers
found that most studies demonstrate a correlation
between CDAD and antibiotics, yet none were able to
deﬁne a causal relationship. They concluded that welldesigned studies grounded in epidemiological principles are needed to identify true risk factors for
CDAD and to provide reliable estimates of the
strength of the association [37]. Although we agree
with those researchers, the analysis presented here of
hospital-level risk factors provides alternative data
regarding CDAD risk.
The present study has a number of strengths and
limitations that are speciﬁc to the use of administrative data. Hospital in-patient discharge ﬁles do not
provide clinical details commonly found in the medical record, such as culture results and treatment details. More information regarding culture results and
treatment patterns would allow us to verify diagnostic
codes while examining other associations. Despite the
inability to conﬁrm the presence of CDAD, others
have used ICD-9 codes to evaluate trends in CDAD
infections [2] while a recent study demonstrated 75 %
sensitivity for this diagnosis [38]. In addition, the
identiﬁed variability in CDAD may have been inﬂuenced by the variable presence of infection control
teams leading to detection bias for those ‘high
CDAD ’ hospitals [39]. These hospitals, however, had
strikingly close correlations with other infections ;
thus, the data demonstrate reliable and signiﬁcant
correlations between ‘high CDAD ’ hospitals and
each of the infections queried in both the larger cohort and across the individual states. Thus, we were
able to analyse risk factors that had not been previously studied in smaller single-institution studies.
The strength of the study is grounded on the representative nature of a large cohort of hospitalized
patients with CDAD in three states across diﬀerent
geographic regions of the United States.
In conclusion, the present study revealed high rates
of CDAD in hospitals that discharge large numbers of
patients with other bacterial pathogens and other
common infections. The analysis revealed large differences in CDAD cases across metropolitan statistical areas and states and that ‘high CDAD ’ hospitals
were more likely to provide transplant services and
have slower turnover of beds, reﬂecting longer hospital lengths of stay. These ﬁndings provide more

920

R. Ricciardi and others

insight into the epidemiology of C. diﬃcile and indicate marked diﬀerences in the burden of CDAD
across localities.
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